How to Get Armour Thyroid in Maine

Why Maine Patients Seek Armour Thyroid Specifically

Armour Thyroid contains both T4 (levothyroxine) and T3 (liothyronine) in the ratio found in porcine thyroid gland. Many patients who remain symptomatic on levothyroxine alone ask about NDT because some feel better on the combination. A 2013 patient-preference crossover study by Hoang et al. (N=70) found that 49% of participants preferred NDT over levothyroxine, citing improved mood, cognition, and energy, even though average weight loss was about 4 lbs greater on NDT during that trial period. [1]

That preference data matters clinically. It tells prescribers that a meaningful subset of hypothyroid patients report quality-of-life differences that are worth discussing. Maine's telehealth framework allows those conversations to happen without a 3-hour drive to an endocrinologist in Portland or Bangor.

Armour Thyroid is FDA-approved as a natural desiccated thyroid extract and carries a long prescribing history in the United States. [2] Each 60 mg (1 grain) tablet contains 38 mcg T4 and 9 mcg T3, a ratio that differs from the approximately 14:1 T4-to-T3 ratio of human thyroid secretion. That physiologic mismatch is the primary reason many endocrinologists start at low doses and titrate slowly.

Who Can Prescribe Armour Thyroid in Maine

Any licensed Maine prescriber with authority to treat thyroid disease may write for Armour Thyroid. The three main categories are physicians (MDs and DOs), nurse practitioners, and physician assistants.

Maine granted NPs full practice authority, meaning a nurse practitioner can independently diagnose, treat, and prescribe Schedule II-V controlled substances as well as standard prescription medications without a mandatory physician co-signature. Armour Thyroid is not a controlled substance, so NP prescribing carries no additional regulatory hurdle. [3]

Physician assistants in Maine operate under a supervising physician agreement. A PA whose collaborating physician permits thyroid disease management may prescribe NDT within that agreement's scope.

Telehealth prescribers must hold an active Maine DEA number if controlled substances are involved. For Armour Thyroid specifically, the prescriber needs only a valid Maine license and a legitimate prescriber-patient relationship established via a synchronous telehealth visit (audio-video) or, in some cases, an asynchronous intake reviewed by a licensed Maine clinician.

HealthRX Maine Prescribing Pathway for Armour Thyroid:

1. Establish care (telehealth or in-person). A synchronous video visit satisfies Maine's telehealth standard of care requirements.
2. Submit baseline labs: TSH, Free T4, Free T3. Add TPO antibodies if Hashimoto's is suspected.
3. Review symptoms with the prescriber. Documented symptom burden (fatigue scoring, weight history, cold intolerance) supports medical necessity for NDT over generic levothyroxine.
4. Receive electronic prescription. Maine pharmacies and mail-order services accept e-prescriptions for Armour Thyroid.
5. Titrate at 4 to 6 weeks. Follow-up labs at that interval guide dose adjustment.

Required Labs Before Getting Armour Thyroid in Maine

Labs are not optional. Prescribing NDT without a documented TSH is below the standard of care in every state, Maine included.

The American Thyroid Association recommends TSH as the primary screening and monitoring test for hypothyroidism. [4] A TSH above 4.5 mIU/L on two separate occasions, or a single TSH above 10 mIU/L, is generally the threshold for initiating thyroid hormone replacement in symptomatic adults.

For patients requesting Armour Thyroid specifically, most clinicians also want Free T4 and Free T3 before prescribing, because the T3 component in NDT can suppress TSH faster than T4-only therapy. Baseline Free T3 helps the prescriber understand where the patient starts and avoids inadvertent T3 excess, which carries cardiovascular risk. The American Association of Clinical Endocrinology notes that serum TSH should be targeted at the lower half of the normal range (approximately 0.5 to 2.5 mIU/L) when managing patients on combination T4/T3 therapy. [5]

Additional labs commonly ordered at HealthRX before starting Armour Thyroid in Maine:

• TPO antibodies (thyroid peroxidase): rules in or out autoimmune Hashimoto's thyroiditis
• Thyroglobulin antibodies: secondary autoimmune marker
• Complete metabolic panel: baseline hepatic and renal function
• Lipid panel: hypothyroidism elevates LDL; confirms need for treatment and tracks improvement
• Morning cortisol: adrenal insufficiency must be treated before thyroid hormone is added, as NDT can precipitate an adrenal crisis in cortisol-deficient patients

Getting all five drawn at one visit saves time and avoids a second lab trip. Most Maine LabCorp and Quest Diagnostics locations can process a standing order from a telehealth provider; results typically return in 24 to 72 hours.

How Telehealth Works for Armour Thyroid in Maine

Maine enacted its telehealth parity law under 24-A M.R.S. section 4316, which requires insurers to cover telehealth services at parity with in-person services. [6] That means a telehealth thyroid consultation billed under appropriate evaluation-and-management codes cannot be reimbursed at a lower rate than the identical in-person visit.

For NDT prescribing specifically, the workflow is straightforward. A patient schedules a video visit with a Maine-licensed clinician, uploads or submits recent lab results (or is sent an order for labs), and the clinician reviews the full history during the synchronous appointment. If the prescriber determines that Armour Thyroid is appropriate, an electronic prescription goes directly to the patient's chosen Maine pharmacy or a mail-order pharmacy licensed to ship to Maine addresses.

Maine does not require an in-person visit prior to prescribing Armour Thyroid. The state follows the federal telehealth standard requiring a valid prescriber-patient relationship, which a synchronous audio-video visit satisfies for non-controlled substances. [7]

Turnaround from initial video visit to pharmacy-ready prescription is typically 24 to 48 hours for patients with labs already in hand. For patients who need labs first, the full timeline runs about 5 to 14 days: 1 to 2 days for lab orders, 1 to 3 days for lab results, then the follow-up prescribing visit, then 1 to 3 business days for pharmacy fulfillment or 2 to 5 days for mail delivery.

Armour Thyroid Pharmacies in Maine

Retail pharmacy chains. CVS, Walgreens, Rite Aid, and Hannaford Pharmacy all stock or can order Armour Thyroid at Maine locations. Call ahead; smaller rural stores may carry only limited grain sizes (typically 30 mg, 60 mg, and 90 mg tablets are most commonly stocked; 120 mg, 180 mg, and 240 mg may require a 24 to 48-hour order).

Mail-order pharmacies. If your Maine insurer uses a preferred mail-order network, Armour Thyroid is generally available through those channels. Express Scripts, OptumRx, and Costco Pharmacy (no membership required for pharmacy services) ship to Maine addresses. A 90-day supply via mail order often costs less out-of-pocket than three 30-day retail fills.

503A compounding pharmacies. Maine-licensed 503A compounding pharmacies may prepare custom NDT formulations (e.g., different grain doses, dye-free capsules, hypoallergenic base) from porcine thyroid powder upon a valid patient-specific prescription. This is distinct from Armour Thyroid by Allergan and is not an FDA-approved finished drug product. Compounded NDT may suit patients with dye sensitivities or those who need non-standard doses. Patients should confirm that the compounding pharmacy holds an active Maine Board of Pharmacy license. [8]

Price without insurance. Armour Thyroid's cash price varies by dose and supplier. At the 60 mg once-daily dose, a 90-day supply runs approximately $55 to $90 at retail; GoodRx and similar discount programs frequently reduce that further. Compounded NDT from a 503A pharmacy typically runs $40 to $80 per 30-day supply depending on dose and formulation.

Maine Medicaid (MaineCare) and Prior Authorization

MaineCare covers Armour Thyroid for the indication of hypothyroidism, but requires prior authorization. [9] Without PA approval, the pharmacy will dispense levothyroxine as the preferred agent. Getting PA approved generally takes 3 to 10 business days and requires the following documentation from the prescribing clinician:

1. Diagnosis code for hypothyroidism (ICD-10: E03.9 or E06.3 for Hashimoto's)
2. Evidence of inadequate response or intolerance to levothyroxine (prior trial dates and doses)
3. Most recent TSH, Free T4, and Free T3 values
4. Clinical rationale for NDT over generic levothyroxine

The American Thyroid Association's 2014 guidelines state: "For the majority of hypothyroid patients, treatment with levothyroxine alone is satisfactory. A trial of combination T4/T3 therapy may be reasonable for hypothyroid patients who, despite normal TSH levels, have continued symptoms." [4] Including that language (or the equivalent clinical framing from the patient's chart) strengthens most PA submissions.

Private Maine insurers (Anthem, Harvard Pilgrim, Martin's Point) have varying formulary positions for Armour Thyroid; some list it on Tier 2 or Tier 3 with no PA requirement, while others mirror the MaineCare PA requirement. Check your specific formulary before assuming coverage.

Transferring an Armour Thyroid Prescription to Maine

Patients relocating to Maine can transfer an active Armour Thyroid prescription from an out-of-state pharmacy to a Maine pharmacy under standard interstate pharmacy transfer rules, provided the prescription has refills remaining and the original prescriber is still licensed in good standing. [10]

What you cannot transfer is the prescriber relationship. If your prescribing physician practices only in Massachusetts, for example, they may not hold an active Maine license and therefore may not continue prescribing for you once you are established in Maine. You will need either a Maine-licensed prescriber or a telehealth platform whose clinicians hold active Maine licenses.

Steps to transfer:

1. Call the Maine pharmacy you want to use and provide the name and phone number of the out-of-state pharmacy.
2. The receiving Maine pharmacist contacts the originating pharmacy and completes the transfer.
3. If the prescription has no refills remaining, you will need a new prescription from a Maine-licensed prescriber before the Maine pharmacy can dispense.

Allow 24 to 48 hours for a standard transfer. Pharmacies cannot transfer a prescription that has already been transferred once in most states, so go directly to your preferred final Maine pharmacy.

Starting Dose, Titration, and Monitoring in Maine

Most Maine prescribers initiate Armour Thyroid at 30 mg (half a grain) daily and titrate upward every 4 to 6 weeks based on symptoms and labs. Patients converting from levothyroxine use a general equivalency of 60 mg Armour Thyroid per 100 mcg levothyroxine, though individual variation is significant and the conversion is approximate. [2]

Monitoring schedule after starting or dose-adjusting:

• 4 to 6 weeks post-change: TSH, Free T4, Free T3
• 6 months after stable dose: TSH and Free T4 (Free T3 if symptoms persist)
• Annually when stable: TSH, Free T4; lipid panel recommended given lipid response to thyroid optimization

Symptoms of T3 excess include palpitations, heat intolerance, unexplained weight loss, tremor, and insomnia. Any patient experiencing these should contact their prescriber before the scheduled follow-up. The FDA label for Armour Thyroid carries a black-box-adjacent warning against use for obesity or weight loss; doses within the euthyroid range do not carry that risk, but supraphysiologic dosing does. [2]

The Endocrine Society's 2019 guidelines note that cardiovascular risk with exogenous thyroid hormone is primarily associated with TSH suppression below 0.1 mIU/L, particularly in patients over 60. [11] Keeping TSH within low-normal range (0.5 to 2.0 mIU/L) on NDT therapy largely mitigates that risk.

Drug Interactions and Special Populations in Maine

Armour Thyroid interacts with several common medications, and Maine patients taking any of the following should disclose them to their prescriber before starting NDT:

• Calcium carbonate and iron supplements: Reduce NDT absorption by up to 40% when taken within 4 hours of the dose. Take Armour Thyroid at least 4 hours apart from these. [12]
• Proton pump inhibitors (omeprazole, pantoprazole): May reduce T4 absorption modestly.
• Warfarin: NDT potentiates warfarin's anticoagulant effect; INR should be checked 4 to 6 weeks after any NDT dose change.
• Diabetes medications: Thyroid optimization alters insulin sensitivity; blood glucose monitoring should increase during the first 4 to 6 weeks on NDT.
• Antidepressants (SSRIs, TCAs): No pharmacokinetic interaction, but thyroid optimization often changes psychiatric medication requirements.

Pregnancy requires special attention. The American College of Obstetricians and Gynecologists recommends levothyroxine (not NDT) as the preferred agent during pregnancy because the T3 component in NDT crosses the placenta poorly and the fixed T4:T3 ratio makes precise T4 dosing harder. [13] Maine patients who become pregnant while on Armour Thyroid should discuss switching to levothyroxine with their OB or endocrinologist promptly.

What the Clinical Evidence Says About NDT Versus Levothyroxine

The evidence base for NDT remains smaller than for levothyroxine, but two controlled trials provide directionally useful data.

Hoang et al. (2013, N=70) ran a randomized crossover trial over two 16-week periods comparing Armour Thyroid to levothyroxine in hypothyroid adults. Patients on NDT lost an average of 4 lbs more, and 49% preferred NDT at study end. Cognitive testing and mood scores favored NDT in patient-reported measures, though objective neuropsychological testing showed no statistically significant difference between groups. [1]

A 2019 systematic review published in Thyroid (Idrees et al.) examined 11 studies comparing combination T4/T3 therapy to T4 alone and found that about one-third of patients reported subjective preference for combination therapy, with no significant difference in most objective outcomes. The authors concluded that individual patient preference is a legitimate clinical factor in prescribing decisions. [14]

Neither trial provides evidence that NDT is universally superior to levothyroxine. What the data support is that a subset of patients feel meaningfully better on NDT, and that prescribers have a defensible evidence base for offering a trial.